| Issue Date | Title | Author(s) |
| 2013 | Diclofenac epolamine medicated plaster in the treatment of minor soft tissue injuries: a multicenter randomized controlled trial | Li, Chunde; Frangione, Valeria; Rovati, Stefano; Zheng, Qingshan |
| 2011 | Efficacy and safety of hemoporfin in photodynamic therapy for port-wine stain: a multicenter and open-labeled phase IIa study | Zhao, Yi; Zhou, Zhanchao; Zhou, Guoyu; Tu, Ping; Zheng, Qingshan; Tao, Jining; Gu, Ying; Zhu, Xuejun |
| 2016 | Hemoporfin Photodynamic Therapy for Port Wine Stain: A Randomized Controlled Trial | Zhao, Yi; Tu, Ping; Zhou, Guoyu; Zhou, Zhanchao; Lin, Xiaoxi; Yang, Huilan; Lu, Zhong; Gao, Tianwen; Tu, Yating; Xie, Hongfu; Zheng, Qingshan; Gu, Ying; Tao, Jining; Zhu, Xuejun |
| Jul-2021 | Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial | Dong, Wenliang; Chen, Min; Niu, Suping; Wang, Bianzhen; Xia, Lin; Wang, Jiaxue; Shen, Tiantian; Wang, Qian; Lv, Jie; Liu, Gang; Fan, Huaying; Xie, Zhenwei; Xie, Fan; An, Youzhong; Zheng, Qingshan; Rao, Huiying; Song, Haifeng; Fang, Yi |
| Feb-2023 | Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Gerilimzumab (GB224), a recombinant humanized interleukin-6 monoclonal antibody, in healthy Chinese adults: A randomized controlled dose-escalation study | Yan, Diqin; Niu, Suping; Hu, Dingyuan; Dong, Wenliang; Sun, Yunjuan; Wang, Qian; Wang, Simin; Gu, Qun; Liu, Gang; Wang, Jiaxue; Chen, Liming; Lv, Jie; Zheng, Qingshan; Song, Haifeng; Fang, Yi |
| 2019 | A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of Proposed Biosimilar GB242 and Reference Infliximab in Healthy Subjects | Zhang, Tan; Chen, Guihong; Liu, Chang; Zu, Li'an; Wang, Qi; Wang, Yitong; Lv, Jie; An, Youzhong; Dong, Lihou; Cheng, Huiyang; Ren, Shengbin; Wang, Qian; Zheng, Qingshan; Song, Haifeng; Fang, Yi |
| 2010 | A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections | Wang, Jin; Xiao, Yonghong; Huang, Wenxiang; Xu, Nan; Bai, Chunxue; Xiu, Qingyu; Mei, Changlin; Zheng, Qingshan |
| 2020 | Randomised, double-blind, multicentre, phase ?/? dose escalation and expansion trial of GR1501 in patients with plaque psoriasis: study protocol | Dong, Wenliang; Nie, Xiaoyan; Wang, Jiaxue; Xia, Lin; Cai, Lin; Wang, Qian; Wang, Wei; Fu, Weixing; Wang, Qi; Shen, Tiantian; Fan, Huaying; Niu, Suping; Cui, Yimin; Zheng, Qingshan; Zhang, Jianzhong; Fang, Yi |
| 15-Jun-2022 | A Randomized Controlled Dose-Escalation Study of LY06006, a Recombinant Humanized Monoclonal Antibody to RANKL, in Chinese Healthy Adults | Niu, Suping; Chen, Min; Yan, Diqin; Liu, Xiangxing; Guo, Shuren; Ou, Lun; Fan, Huaying; Lv, Jie; Wang, Qian; Dong, Wenliang; Xia, Lin; Wang, Simin; Liu, Gang; Gu, Qun; Guo, Danjie; Liu, Hongxia; Rao, Huiying; Zheng, Qingshan; Nie, Xiaoyan; Song, Haifeng; Fang, Yi |
| Jun-2020 | A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection and trastuzumab in healthy Chinese adults | Wang, Jiaxue; Niu, Suping; Dong, Wenliang; Wei, Li; Ou, Lun; Zhang, Tan; Zhang, Liangbi; Nie, Xiaoyan; Wang, Qian; Shen, Tiantian; Wang, Qi; Xia, Lin; Liu, Gang; Jin, Jiting; Zheng, Qingshan; Song, Haifeng; Fang, Yi |
| 2020 | Safety and tolerability of a single dose T0001 in Chinese healthy adult volunteers: a first-in-human ascending dose study | Zhang, Tan; Zhang, Minjie; Zu, Li'an; Wang, Qian; Wang, Qi; Wang, Wei; Wang, Yitong; Zang, Yannan; Xie, Zhenwei; Chen, Shi; Wang, Mei; Zheng, Qingshan; Li, Zhanguo; Chen, Guihong; Fang, Yi |
